Kenneth W. O'Keefe - 07 Mar 2023 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role: Director
Signature: By: /s/Adam Guttmann, as attorney in fact For: Kenneth W O'Keefe
Issuer symbol: JAZZ
Transactions as of: 07 Mar 2023
Net transactions value: -$4,347
Form type: 4
Filing time: 09 Mar 2023, 17:34:12 UTC
Previous filing: 09 Aug 2022
Next filing: 15 Aug 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAZZ	Ordinary Shares	Options Exercise	$367,920	+4,500	+21%	$81.76	25,579	07 Mar 2023	Direct
transaction	JAZZ	Ordinary Shares	Sale	$372,267	-2,690	-11%	$138.39	22,889	07 Mar 2023	Direct	F1
holding	JAZZ	Ordinary Shares						4,445	07 Mar 2023	by Trust	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JAZZ	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-4,500	-100%	$0.000000^*	0	07 Mar 2023	Ordinary Shares	4,500	$81.76	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares sold to pay option price from the exercise of stock options.
F2	Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.
F3	This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. This option vested in 12 equal monthly installments beginning on September 1, 2013.